Entries by Dr. Emmanuel Egbroko

3 THINGS YOU SHOULD KNOW ABOUT PAXLOVID

  Paxlovid is an oral antiviral medication for the treatment of COVID-19. It was developed by Pfizer for the treatment of mild-to-moderate COVID-19 in adults at high risk for severe disease, including hospitalization and death. The Food and Drug Administration (FDA) first made Paxlovid available in December 2021 under emergency use authorization for high-risk individuals […]

International Vaccinology Course

International Vaccine Institute: International Vaccinology Course     The five-day course will be held virtually and free of charge. Participants will gain a comprehensive over view of vaccinology with a focus on COVID-19, featuring lectures from distinguished experts across global health and vaccine organizations including WHO, GAVI, CEPI, U.S National Institute of Health, National Vaccine […]